Copy
Novateur Portfolio Company Closes $12 Million Series A Financing

Get Ready For BioEurope®

BioEurope Partnering: Are Your Meeting Requests Getting Rejected or Never Answered?

Find out how you can improve your chances of securing more meetings in our latest blog, authored by our very own Dr. Anne Assmus.

read more


CLIENT DEALS, PARTNERSHIPS & INVESTMENTS

 
read more

FELDAN THERAPEUTICS

Feldan Therapeutics closed a $12.5 million Series A financing round led by GC, the parent company of GC Pharma, with the participation of Stonebridge Ventures, Anges Québec Capital, including members of Anges Québec, and existing investors. 

FOR MORE INFO CLICK HERE

 


Feldan Therapeutics, along with the University of Iowa were awarded a US $4 million Grant by the National Heart, Lung, and Blood Institute of the National Institutes of Health. Congrats to the dedicated team at Feldan and Dr. Paul McCray from the University of Iowa Carver College of Medicine.

FOR MORE INFO CLICK HERE

 

Business Development Executive Advisory Suite

Working with clients to prepare client’s presentations, engage pharmaceutical partners, negotiate and execute licensing.

Meet our newest Business Development Executive:

Paul Brennan
Global Business Development Lead

(Aquinox, InMed, Arbutus Biopharma,Aspreva,Tekmira)

Dr. Anne Assmus
Global Lead BD/Platform and Therapeutics

(Affimed, Immatics, MorphoSys, Novozymes)

Jack Tupman
Senior Pharma Business Development Advisor

(Sr VP Eli Lilly and Company)

Simran Kohli
Marketing Communications Specialist

(Previously: BULLSEYE CX)





UPCOMING
EVENTS

Novateur Executives will be attending these upcoming events. Reach out and meet with us.


LifeSciences BC Investor Summit 2018 presented by Lumira Ventures

October 25, 2018 - Vancouver, BC

MORE INFO


Life Sciences Summit 2018

October 24-25, 2018 - New York, NY

MORE INFO


LifeSciences BC Workshop: How to be Investor Ready

November 1, 2018 - Vancouver, BC

MORE INFO


BIO-EUROPE 2018

November 5-7, 2018 - Copenhagen, DK

MORE INFO





RECENT
EVENTS

 

GLOBAL PERSPECTIVES ON EARLY-STAGE INVESTMENT & PARTNERING

With over 130 Life Sciences entrepreneurs, innovators, investors and strategists in attendance, the Global Perspectives on Early-Stage Investment and Partnering summit, hosted by Novateur Ventures and Accel-Rx was recognized as a “first of its kind” event held in Vancouver.

In the midst of the beautiful VanDusen Botanical Gardens, 6 expert panelists from leading Pharma and Venture Capitals, from across the US, Europe and China discussed topics pertaining to how life sciences start-ups and early-stage innovators should structure themselves to partner with big pharma or seek funding from venture capitals.

MORE INFO

Natalie Dakers, Founding President and Chief Executive Officer of Accel-Rx and Ali Ardakani, Founder & Managing Director of Novateur Ventures, gave welcoming remarks at the Global Perspectives on Early-Stage Investment & Partnering event on Oct 3, 2018.



Ali Ardakani, Founder & Managing Director of Novateur was moderating the panel Demystifying Chinese Venture Capital; A US Perspective on the Current Climate for Investments & IPOs.


 


THE ADVENTURE EXPERIENCE

The AdVENTURE Experience, organized by Novateur Ventures and Accel-Rx was a unique opportunity for Canadian Entrepreneurs and Innovators in Life Sciences and Biotechnology to connect with and forge mutually beneficial relationships with key strategists and foreign investors, while exploring British Columbia's beautiful back country.

MORE INFO

Participants of the AdVENTURE Experience hosted by Novateur Ventures and Accel-Rx, upon arriving at the Squamish Airport on Oct 4, 2018.



Hiking the alpine back country and soaking in the amazing mountaintop views at the AdVENTURE Experience on Oct 4, 2018.


BIOTECanada Article

BIOTECanada published an article on how Life Sciences companies can benefit from the vast network of expertise Novateur provides.
 

READ MORE

+1 844 200 6682
Toll free USA & Canada
 
download our presentation
Copyright © 2018 Novateur Ventures Inc., All rights reserved.


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.